<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Biote Corp — News on 6ix</title>
<link>https://6ix.com/company/biote-corp</link>
<description>Latest news and press releases for Biote Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/biote-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835507d78dffbe2df0e738a.webp</url>
<title>Biote Corp</title>
<link>https://6ix.com/company/biote-corp</link>
</image>
<item>
<title>Biote Schedules First Quarter 2026 Financial Results Release and Conference Call</title>
<link>https://6ix.com/company/biote-corp/news/biote-schedules-first-quarter-2026-financial-results-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-schedules-first-quarter-2026-financial-results-release-and-conference-call</guid>
<pubDate>Wed, 22 Apr 2026 20:05:00 GMT</pubDate>
<description>IRVING, Texas, April 22, 2026--biote Corp. (Nasdaq: BTMD) ("Biote" or the "Company"), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners’ patients, today announced the Company will provide first quarter financial results on Wednesday, May 6, 2026, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.</description>
</item>
<item>
<title>Biote Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/biote-corp/news/biote-reports-fourth-quarter-and-full-year-2025-financial-results-23</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-reports-fourth-quarter-and-full-year-2025-financial-results-23</guid>
<pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
<description>Executing efficiently on strategic priorities Continued salesforce expansion to capture large growth opportunity Anticipate a return to procedure revenue</description>
</item>
<item>
<title>Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call</title>
<link>https://6ix.com/company/biote-corp/news/biote-schedules-fourth-quarter-and-full-year-2025-financial-results-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-schedules-fourth-quarter-and-full-year-2025-financial-results-release-and-conference-call</guid>
<pubDate>Wed, 25 Feb 2026 05:00:00 GMT</pubDate>
<description>IRVING, Texas--(BUSINESS WIRE)-- biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator advancing the healthspan of patients’ lives by</description>
</item>
<item>
<title>Biote Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/biote-corp/news/biote-reports-third-quarter-2025-210500846</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-reports-third-quarter-2025-210500846</guid>
<pubDate>Wed, 05 Nov 2025 21:05:00 GMT</pubDate>
<description>IRVING, Texas, November 05, 2025--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners’ patients, today announced financial results for the third quarter ended September 30, 2025.</description>
</item>
<item>
<title>Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call</title>
<link>https://6ix.com/company/biote-corp/news/biote-schedules-third-quarter-2025-200500423</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-schedules-third-quarter-2025-200500423</guid>
<pubDate>Wed, 22 Oct 2025 20:05:00 GMT</pubDate>
<description>IRVING, Texas, October 22, 2025--biote Corp. (Nasdaq: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide third quarter financial results on Wednesday, November 5, 2025, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.</description>
</item>
<item>
<title>Biote Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/biote-corp/news/biote-reports-second-quarter-2025-200500062</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-reports-second-quarter-2025-200500062</guid>
<pubDate>Wed, 06 Aug 2025 20:05:00 GMT</pubDate>
<description>IRVING, Texas, August 06, 2025--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the second quarter ended June 30, 2025.</description>
</item>
<item>
<title>Biote Schedules Second Quarter 2025 Financial Results Release and Conference Call</title>
<link>https://6ix.com/company/biote-corp/news/biote-schedules-second-quarter-2025-200500946</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-schedules-second-quarter-2025-200500946</guid>
<pubDate>Wed, 23 Jul 2025 20:05:00 GMT</pubDate>
<description>IRVING, Texas, July 23, 2025--biote Corp. (Nasdaq: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide second quarter financial results on Wednesday, August 6, 2025, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.</description>
</item>
<item>
<title>Biote Names Rich Barrera to Board of Directors</title>
<link>https://6ix.com/company/biote-corp/news/biote-names-rich-barrera-board-200500118</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-names-rich-barrera-board-200500118</guid>
<pubDate>Mon, 09 Jun 2025 20:05:00 GMT</pubDate>
<description>IRVING, Texas, June 09, 2025--biote Corp.(NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that its Board of Directors has elected Rich Barrera to the Board, effective immediately.</description>
</item>
<item>
<title>Biote Reports First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/biote-corp/news/biote-reports-first-quarter-2025-200500820</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-reports-first-quarter-2025-200500820</guid>
<pubDate>Wed, 07 May 2025 20:05:00 GMT</pubDate>
<description>IRVING, Texas, May 07, 2025--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the first quarter ended March 31, 2025.</description>
</item>
<item>
<title>Biote Schedules First Quarter 2025 Financial Results Release and Conference Call</title>
<link>https://6ix.com/company/biote-corp/news/biote-schedules-first-quarter-2025-200500469</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-schedules-first-quarter-2025-200500469</guid>
<pubDate>Wed, 23 Apr 2025 20:05:00 GMT</pubDate>
<description>IRVING, Texas, April 23, 2025--biote Corp. (Nasdaq: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide first quarter financial results on Wednesday, May 7, 2025, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.</description>
</item>
<item>
<title>Biote Announces Purchase of Shares by Directors and CEO</title>
<link>https://6ix.com/company/biote-corp/news/biote-announces-purchase-shares-directors-213000258</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-announces-purchase-shares-directors-213000258</guid>
<pubDate>Tue, 18 Mar 2025 21:30:00 GMT</pubDate>
<description>IRVING, Texas, March 18, 2025--biote Corp. (NASDAQ: BTMD) ("Biote" or the "Company") a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that several members of its Board of Directors, along with CEO Bret Christensen, have made open market purchases of Biote’s common stock, acquiring an aggregate of approximately 260,000 shares.</description>
</item>
<item>
<title>Biote Reports Fourth Quarter and Full Year 2024 Financial Results</title>
<link>https://6ix.com/company/biote-corp/news/biote-reports-fourth-quarter-full-200500596</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-reports-fourth-quarter-full-200500596</guid>
<pubDate>Wed, 12 Mar 2025 20:05:00 GMT</pubDate>
<description>IRVING, Texas, March 12, 2025--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the fourth quarter and full year ended December 31, 2024.</description>
</item>
<item>
<title>Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call</title>
<link>https://6ix.com/company/biote-corp/news/biote-schedules-fourth-quarter-full-210500818</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-schedules-fourth-quarter-full-210500818</guid>
<pubDate>Wed, 26 Feb 2025 21:05:00 GMT</pubDate>
<description>IRVING, Texas, February 26, 2025--biote Corp. (Nasdaq: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide fourth quarter and full year financial results on Wednesday, March 12, 2025, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.</description>
</item>
<item>
<title>Biote Announces CEO Retirement and Succession Plan</title>
<link>https://6ix.com/company/biote-corp/news/biote-announces-ceo-retirement-and-succession-plan</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-announces-ceo-retirement-and-succession-plan</guid>
<pubDate>Thu, 30 Jan 2025 05:00:00 GMT</pubDate>
<description>Terry Weber Retiring as CEO and Director and Transitioning to Strategic Advisor to Company’s Board of Directors Health Care Veteran Bret Christensen to</description>
</item>
<item>
<title>Biote Reports Third Quarter 2024 Financial Results</title>
<link>https://6ix.com/company/biote-corp/news/biote-reports-third-quarter-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-reports-third-quarter-2024-financial-results</guid>
<pubDate>Tue, 12 Nov 2024 05:00:00 GMT</pubDate>
<description>Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to</description>
</item>
<item>
<title>Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call</title>
<link>https://6ix.com/company/biote-corp/news/biote-schedules-third-quarter-2024-financial-results-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-schedules-third-quarter-2024-financial-results-release-and-conference-call</guid>
<pubDate>Tue, 29 Oct 2024 04:00:00 GMT</pubDate>
<description>IRVING, Texas--(BUSINESS WIRE)-- biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the</description>
</item>
<item>
<title>Biote Reports Second Quarter 2024 Financial Results</title>
<link>https://6ix.com/company/biote-corp/news/biote-reports-second-quarter-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-reports-second-quarter-2024-financial-results</guid>
<pubDate>Thu, 08 Aug 2024 04:00:00 GMT</pubDate>
<description>Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance</description>
</item>
<item>
<title>Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call</title>
<link>https://6ix.com/company/biote-corp/news/biote-schedules-second-quarter-2024-financial-results-release-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-schedules-second-quarter-2024-financial-results-release-and-conference-call</guid>
<pubDate>Thu, 25 Jul 2024 04:00:00 GMT</pubDate>
<description>IRVING, Texas--(BUSINESS WIRE)-- biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the</description>
</item>
<item>
<title>Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares</title>
<link>https://6ix.com/company/biote-corp/news/biote-announces-dollar60-million-agreement-to-repurchase-83-million-shares-and-cancel-approximately-40-million-earnout-shares</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-announces-dollar60-million-agreement-to-repurchase-83-million-shares-and-cancel-approximately-40-million-earnout-shares</guid>
<pubDate>Thu, 20 Jun 2024 04:00:00 GMT</pubDate>
<description>IRVING, Texas--(BUSINESS WIRE)-- biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the</description>
</item>
<item>
<title>Biote Reports First Quarter 2024 Financial Results</title>
<link>https://6ix.com/company/biote-corp/news/biote-reports-first-quarter-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/biote-corp/news/biote-reports-first-quarter-2024-financial-results</guid>
<pubDate>Tue, 07 May 2024 04:00:00 GMT</pubDate>
<description>Procedure revenue growth and strengthened profitability drive solid financial performance Phased launch of BioteRx remains on track Reaffirms 2024 financial</description>
</item>
</channel>
</rss>